Stopping cancer before it starts remains one of the biggest challenges in modern medicine.
For people born with a high genetic risk, prevention often means years of intensive screening or life-altering surgery, long before any disease is detected.
Researchers have long searched for ways to intervene earlier, without removing healthy tissue. New findings suggest the immune system itself may offer a different path.
A new prevention strategy
Scientists at the University of Texas MD Anderson Cancer Center have reported early results from a clinical trial testing an experimental cancer vaccine designed to prevent, rather than treat, cancer.
Also read: Health expert outlines reasons for frequent night urination
The study, published in Nature Medicine, explores whether the immune system can be trained to identify and eliminate abnormal cells before they develop into tumors.
The approach is part of a broader scientific effort known as cancer interception, which aims to stop disease at its earliest biological stages.
Who the research focuses on
The trial involved people with Lynch syndrome, a hereditary condition caused by mutations in DNA repair genes.
Carriers face a significantly higher lifetime risk of several cancers, including colorectal and endometrial cancer, often developing disease at a younger age than the general population.
Also read: New study shows when fitness and strength begin to decline
Current management relies on frequent screenings and, in some cases, preventive surgery, measures that can affect quality of life over decades.
Early trial results
The investigational vaccine, called NOUS-209, was tested in 45 participants in a Phase Ib/II study.
Researchers found the vaccine was generally well tolerated and triggered strong immune responses.
Laboratory testing showed immune cells activated by the vaccine could recognise and destroy cancer-related targets.
Also read: Study finds obesity and high blood pressure may cause dementia
After one year, researchers observed fewer precancerous lesions and no new advanced polyps, offering early signs that immune-based prevention may be possible.
What comes next
The study was small and not designed to prove long-term cancer prevention. Larger trials will be needed to confirm durability and real-world benefit.
Even so, the results point toward a future where cancer prevention may rely on immunity, not surgery.
Sources: News Medical and Nature Medicine
Also read: Pork fat ranks higher than vegetables in new nutrition analysis
Also read: Long-term diabetes treatment studied in relation to cancer outcomes